GlassScriptPhysician profile
Yoganand J Hiremath
NPI 1952377863
$3,904.94
in general payments reported to CMS, 2019-2025
26 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $111 · 2021: $432 · 2022: $369 · 2023: $614 · 2024: $744 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,556 · Travel and Lodging: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.54 |
| Travel and Lodging | $116.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $751.35 | 2019-2025 | Cardiomems, Jot Dx |
| Boston Scientific Corporation | $563.67 | 2020-2025 | Avvigo Guidance System, Opticross, Rotapro |
| Cvrx, INC. | $450.89 | 2023-2025 | Barostim Neo System |
| Inari Medical, INC. | $448.90 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $361.89 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $328.81 | 2019-2025 | |
| Medtronic, INC. | $175.10 | 2023-2025 | Corevalve Evolut R, Onyx Frontier |
| Heartflow, INC. | $147.63 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $125.65 | 2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $102.10 | 2023-2025 | Verquvo |
| Stryker Corporation | $94.14 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Janssen Pharmaceuticals, INC | $51.06 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $40.61 | 2019-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.29 | 2019-2023 | Lifevest |
| Cardiovascular Systems INC. | $30.02 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $29.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biohaven Pharmaceuticals, INC. | $20.65 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $19.37 | 2023 | Camzyos |
| Impulse Dynamics (USA) INC. | $19.16 | 2023 | Optimizer |
| Amarin Pharma, INC. | $15.12 | 2019 | |
| Terumo Medical Corporation | $14.52 | 2023 | Glidewire, Heartrail |
| Kestra Medical Technology Services, INC. | $14.41 | 2023 | Assure Wcd |
| Glaxosmithkline, LLC. | $13.63 | 2020 | |
| Atricure, INC. | $13.45 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoganand Hiremath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.